10 Colorectal Cancer Clinical Trials in Atlanta, GA (2026)

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Recruiting Colorectal Cancer Studies in Atlanta

NCT07215000Recruiting

Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial

The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene ...

Atlanta, GAPHASE4300 participantsMorehouse School of Medicine

View Study Details

NCT06205485Recruiting

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiat...

Atlanta, GAPHASE3250 participantsCanadian Cancer Trials Group

View Study Details

NCT06882746Recruiting

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

This study is open to adults with advanced cancer of the colon, rectum, stomach, or pancreas, that is the cancer cannot be removed by surgery or has spread. People can take part in this study if their...

Atlanta, GAPHASE1135 participantsBoehringer Ingelheim

View Study Details

NCT06937177Recruiting

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

This is a randomized, double-blind, placebo-controlled study of B07, administered daily by subcutaneous (SC) injection, in up to 120 patients with newly diagnosed metastatic colorectal cancer. This st...

Atlanta, GAPHASE2120 participantsEndevica Bio

View Study Details

NCT07321106Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 in participants with advanced or metastatic Microsatellite Stable (MSS)/Microsatellite Insta...

Atlanta, GAPHASE180 participantsCartography Biosciences

View Study Details

NCT06562543Recruiting

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American an...

Atlanta, GAPHASE478 participantsTakeda

View Study Details

NCT07446322Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

This is an open-label, randomized, multicenter Phase 2 study to assess the efficacy and safety of FOLFIRI + bevacizumab + pelareorep vs. FOLFIRI + bevacizumab in patients with RAS-mutated, MSS mCRC wh...

Atlanta, GAPHASE260 participantsOncolytics Biotech

View Study Details

NCT05663203Recruiting

A Web-Based Dyadic Intervention for Colorectal Cancer

This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal canc...

Atlanta, GANA56 participantsEmory University

View Study Details

NCT07140679Recruiting

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

This phase II trial tests how well immunotherapy (toripalimab) works for reducing the risk of cancer recurrence after surgery in patients with mismatch repair deficient stage IIB, IIC, or III colon ca...

Atlanta, GAPHASE240 participantsEmory University

View Study Details

NCT07405476Recruiting

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

This phase II trial studies how well giving zanidatamab before surgery (neoadjuvant) works in treating patients with colon and rectal cancer that is human epidermal growth factor receptor 2 positive (...

Atlanta, GAPHASE238 participantsEmory University

View Study Details

About Colorectal Cancer Clinical Trials in Atlanta

Colorectal cancer starts in the colon or rectum and is the third most common cancer diagnosed in both men and women. Early detection through screening significantly improves outcomes. Treatments include surgery, chemotherapy, radiation, and targeted therapies.

There are currently 10 colorectal cancer clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 1,157 participants. Research is being sponsored by Morehouse School of Medicine, Canadian Cancer Trials Group, Boehringer Ingelheim and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Colorectal Cancer Clinical Trials in Atlanta — FAQ

Are there colorectal cancer clinical trials in Atlanta?

Yes, there are 10 colorectal cancer clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What colorectal cancer treatments are being tested?

The 10 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for colorectal cancer.

Data updated July 18, 2026 from ClinicalTrials.gov